What is the role of virus vaccination in patients with asthma?

Herman J Bueving, Johannes C van der Wouden

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

It is estimated that viruses play a role in 30% to 80% of asthma exacerbations. Thus, virus vaccination in patients with asthma could play an important role in preventing asthma exacerbations and other complications. Influenza is the only agent for which a routine vaccine is currently available. This article discusses whether influenza vaccination in patients with asthma, based on the available evidence, is justified. Cost-effectiveness of (influenza) vaccination for patients with asthma is questionable. For the other major viruses involved, the present state of affairs is described. Although progress is being made, a vaccine may be available in the near future only for respiratory syncytial virus (RSV). Meanwhile, clinicians and patients should aim for an optimal treatment with the currently available asthma medication.

Original languageEnglish
Pages (from-to)72-6
Number of pages5
JournalCurrent Allergy and Asthma Reports
Volume7
Issue number1
Publication statusPublished - Apr 2007

Cite this